| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
UCSF Comprehensive Cancer Center [P. P. M., W. L. K., A. B. O., K. C., C. C., D. Po.], Cancer Research Institute [D. S., D. A.], Department of Laboratory Medicine [D. Pi., J. W. G.], Department of Surgery [D. J.], and Department of Pathology [P. A. T.], University of California, San Francisco, California 94143
Genomic abnormalities at 348 loci encoding genes that may contribute to lung cancer transformation and progression were assessed using array comparative genomic hybridization in 21 squamous carcinomas (SqCas) and 16 adenocarcinomas (AdCas). Hierarchical clustering showed a clear pattern of gains and losses for the SqCas, whereas the pattern for AdCas was less distinct. Cross-validated classification using a K-nearest-neighbor assigned, on average, 32 of 37 samples to their proper histological subtype. The most noticeable differences between SqCas and AdCas were gain of chromosome 3q22-q26 and loss of chromosome 3p. These occurred almost exclusively in SqCas. The region of recurrent increase is
30 Mb in extent, ranging from EVI1 to TFRC. PIK3CA, the
catalytic subunit of phosphatidylinositol 3-kinase (PI3K), is in this region. The PIK3CA copy number increase was validated using fluorescence in situ hybridization to lung cancer tissue microarrays. Activity of the downstream PI3K effector protein kinase B (PKB) was higher in SqCas than in AdCas and was correlated with PIK3CA copy number (r = 0.75), suggesting that these copy number increases contribute to activation of PI3K signaling in SqCas of the lung.
This article has been cited by other articles:
![]() |
B. Markman, F. Atzori, J. Perez-Garcia, J. Tabernero, and J. Baselga Status of PI3K inhibition and biomarker development in cancer therapeutics Ann. Onc., August 27, 2009; (2009) mdp347v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ocak, M. L. Sos, R. K. Thomas, and P. P. Massion High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications Eur. Respir. J., August 1, 2009; 34(2): 489 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lin, X. Jiang, Y. Shen, M. Li, H. Ma, M. Xing, and Y. Lu Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors Endocr. Relat. Cancer, March 1, 2009; 16(1): 301 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Massion, Y. Zou, H. Chen, A. Jiang, P. Coulson, C. I. Amos, X. Wu, I. Wistuba, Q. Wei, Y. Shyr, et al. Smoking-related Genomic Signatures in Non-Small Cell Lung Cancer Am. J. Respir. Crit. Care Med., December 1, 2008; 178(11): 1164 - 1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamamoto, H. Shigematsu, M. Nomura, W. W. Lockwood, M. Sato, N. Okumura, J. Soh, M. Suzuki, I. I. Wistuba, K. M. Fong, et al. PIK3CA Mutations and Copy Number Gains in Human Lung Cancers Cancer Res., September 1, 2008; 68(17): 6913 - 6921. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Dave, S. E. Wert, T. Tanner, A. R. Thitoff, D. E. Loudy, and J. A. Whitsett Conditional Deletion of Pten Causes Bronchiolar Hyperplasia Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 337 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Engelman The Role of Phosphoinositide 3-Kinase Pathway Inhibitors in the Treatment of Lung Cancer Clin. Cancer Res., August 1, 2007; 13(15): 4637s - 4640s. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, P. Hou, H. Yu, W. Wang, M. Ji, S. Zhao, S. Yan, X. Sun, D. Liu, B. Shi, et al. High Prevalence and Mutual Exclusivity of Genetic Alterations in the Phosphatidylinositol-3-Kinase/Akt Pathway in Thyroid Tumors J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2387 - 2390. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pelosi, B. Del Curto, M. Trubia, A. G. Nicholson, M. Manzotti, G. Veronesi, L. Spaggiari, P. Maisonneuve, F. Pasini, A. Terzi, et al. 3q26 Amplification and Polysomy of Chromosome 3 in Squamous Cell Lesions of the Lung: A Fluorescence In situ Hybridization Study Clin. Cancer Res., April 1, 2007; 13(7): 1995 - 2004. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xia, H. Srinivas, Y.-h. Ahn, G. Sethi, X. Sheng, W. K. A. Yung, Q. Xia, P. J. Chiao, H. Kim, P. H. Brown, et al. Mitogen-activated Protein Kinase Kinase-4 Promotes Cell Survival by Decreasing PTEN Expression through an NF{kappa}B-dependent Pathway J. Biol. Chem., February 9, 2007; 282(6): 3507 - 3519. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Sunde, H. Donninger, K. Wu, M. E. Johnson, R. G. Pestell, G. S. Rose, S. C. Mok, J. Brady, T. Bonome, and M. J. Birrer Expression Profiling Identifies Altered Expression of Genes That Contribute to the Inhibition of Transforming Growth Factor-{beta} Signaling in Ovarian Cancer. Cancer Res., September 1, 2006; 66(17): 8404 - 8412. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mohapatra, R. A. Betensky, E. R. Miller, B. Carey, L. D. Gaumont, D. A. Engler, and D. N. Louis Glioma Test Array for Use with Formalin-Fixed, Paraffin-Embedded Tissue: Array Comparative Genomic Hybridization Correlates with Loss of Heterozygosity and Fluorescence in Situ Hybridization J. Mol. Diagn., May 1, 2006; 8(2): 268 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Bussey, K. Chin, S. Lababidi, M. Reimers, W. C. Reinhold, W.-L. Kuo, F. Gwadry, Ajay, H. Kouros-Mehr, J. Fridlyand, et al. Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel. Mol. Cancer Ther., April 1, 2006; 5(4): 853 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Isakoff, J. A. Engelman, H. Y. Irie, J. Luo, S. M. Brachmann, R. V. Pearline, L. C. Cantley, and J. S. Brugge Breast Cancer-Associated PIK3CA Mutations Are Oncogenic in Mammary Epithelial Cells Cancer Res., December 1, 2005; 65(23): 10992 - 11000. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-M. Kim, S.-H. Yim, J.-S. Lee, M.-S. Kwon, J.-W. Ryu, H.-M. Kang, H. Fiegler, N. P. Carter, and Y.-J. Chung Genome-Wide Screening of Genomic Alterations and Their Clinicopathologic Implications in Non-Small Cell Lung Cancers Clin. Cancer Res., December 1, 2005; 11(23): 8235 - 8242. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Denlinger, B. K. Rundall, and D. R. Jones Inhibition of phosphatidylinositol 3-kinase/Akt and histone deacetylase activity induces apoptosis in non-small cell lung cancer in vitro and in vivo J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1422 - 1429. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. E. Miller Pathogenesis of Lung Cancer: 100 Year Report Am. J. Respir. Cell Mol. Biol., September 1, 2005; 33(3): 216 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wu, E. Mambo, Z. Guo, S. Hu, X. Huang, S. M. Gollin, B. Trink, P. W. Ladenson, D. Sidransky, and M. Xing Uncommon Mutation, but Common Amplifications, of the PIK3CA Gene in Thyroid Tumors J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4688 - 4693. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tonon, K.-K. Wong, G. Maulik, C. Brennan, B. Feng, Y. Zhang, D. B. Khatry, A. Protopopov, M. J. You, A. J. Aguirre, et al. High-resolution genomic profiles of human lung cancer PNAS, July 5, 2005; 102(27): 9625 - 9630. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhao, B. A. Weir, T. LaFramboise, M. Lin, R. Beroukhim, L. Garraway, J. Beheshti, J. C. Lee, K. Naoki, W. G. Richards, et al. Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis Cancer Res., July 1, 2005; 65(13): 5561 - 5570. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wislez, M. L. Spencer, J. G. Izzo, D. M. Juroske, K. Balhara, D. D. Cody, R. E. Price, W. N. Hittelman, I. I. Wistuba, and J. M. Kurie Inhibition of Mammalian Target of Rapamycin Reverses Alveolar Epithelial Neoplasia Induced by Oncogenic K-ras Cancer Res., April 15, 2005; 65(8): 3226 - 3235. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Buonamici, D. Li, F. M. Mikhail, A. Sassano, L. C. Platanias, O. Colamonici, J. Anastasi, and G. Nucifora EVI1 Abrogates Interferon-{alpha} Response by Selectively Blocking PML Induction J. Biol. Chem., January 7, 2005; 280(1): 428 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. TONON, C. BRENNAN, A. PROTOPOPOV, G. MAULIK, B. FENG, Y. ZHANG, D.B. KHATRY, M.J. YOU, A.J. AGUIRRE, E.S. MARTIN, et al. Common and Contrasting Genomic Profiles among the Major Human Lung Cancer Subtypes Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 11 - 24. [Abstract] [PDF] |
||||
![]() |
P. P. Massion, P. M. Taflan, Y. Shyr, S. M. J. Rahman, P. Yildiz, B. Shakthour, M. E. Edgerton, M. Ninan, J. J. Andersen, and A. L. Gonzalez Early Involvement of the Phosphatidylinositol 3-Kinase/Akt Pathway in Lung Cancer Progression Am. J. Respir. Crit. Care Med., November 15, 2004; 170(10): 1088 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Lee, H. Moon, K.-H. Chun, Y.-S. Chang, K. Hassan, L. Ji, R. Lotan, F. R. Khuri, and W. K. Hong Effects of Insulin-like Growth Factor Binding Protein-3 and Farnesyltransferase Inhibitor SCH66336 on Akt Expression and Apoptosis in Non-Small-Cell Lung Cancer Cells J Natl Cancer Inst, October 20, 2004; 96(20): 1536 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Paris, A. Andaya, J. Fridlyand, A. N. Jain, V. Weinberg, D. Kowbel, J. H. Brebner, J. Simko, J.E. V. Watson, S. Volik, et al. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors Hum. Mol. Genet., July 1, 2004; 13(13): 1303 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sonoda, I. Imoto, J. Inoue, T. Shibata, Y. Shimada, K. Chin, M. Imamura, T. Amagasa, J. W. Gray, S. Hirohashi, et al. Frequent Silencing of Low Density Lipoprotein Receptor-Related Protein 1B (LRP1B) Expression by Genetic and Epigenetic Mechanisms in Esophageal Squamous Cell Carcinoma Cancer Res., June 1, 2004; 64(11): 3741 - 3747. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Westfall and J. A. Pietenpol p63: molecular complexity in development and cancer Carcinogenesis, June 1, 2004; 25(6): 857 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Normanno, M. Di Maio, F. Perrone, and M. Campiglio Molecular Markers to Predict Response to Gefitinib: EGFR, ErbB-2, or More? J. Clin. Oncol., May 15, 2004; 22(10): 2035 - 2036. [Full Text] [PDF] |
||||
![]() |
J. M. Kurie Role of Protein Kinase B-Dependent Signaling in Lung Tumorigenesis Chest, May 1, 2004; 125(5_suppl): 141S - 144S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Carbone Lung Cancer: Early Events, Early Interventions: Conference Summary for the 46th Annual Thomas L. Petty Aspen Lung Conference Chest, May 1, 2004; 125(5_suppl): 167S - 172S. [Full Text] [PDF] |
||||
![]() |
C. Q. Zhu, F. H. Blackhall, M. Pintilie, P. Iyengar, N. Liu, J. Ho, T. Chomiak, D. Lau, T. Winton, F. A. Shepherd, et al. Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker Clin. Cancer Res., March 15, 2004; 10(6): 1984 - 1991. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Barbieri, C. E. Barton, and J. A. Pietenpol {Delta}Np63{alpha} Expression Is Regulated by the Phosphoinositide 3-Kinase Pathway J. Biol. Chem., December 19, 2003; 278(51): 51408 - 51414. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Massion, P. M. Taflan, S. M. Jamshedur Rahman, P. Yildiz, Y. Shyr, M. E. Edgerton, M. D. Westfall, J. R. Roberts, J. A. Pietenpol, D. P. Carbone, et al. Significance of p63 Amplification and Overexpression in Lung Cancer Development and Prognosis Cancer Res., November 1, 2003; 63(21): 7113 - 7121. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yokoi, K. Yasui, T. Iizasa, I. Imoto, T. Fujisawa, and J. Inazawa TERC Identified as a Probable Target within the 3q26 Amplicon That Is Detected Frequently in Non-Small Cell Lung Cancers Clin. Cancer Res., October 15, 2003; 9(13): 4705 - 4713. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Imoto, Y. Yuki, I. Sonoda, T. Ito, Y. Shimada, M. Imamura, and J. Inazawa Identification of ZASC1 Encoding a Kruppel-like Zinc Finger Protein as a Novel Target for 3q26 Amplification in Esophageal Squamous Cell Carcinomas Cancer Res., September 15, 2003; 63(18): 5691 - 5696. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, N. Yang, D. Katsaros, W. Huang, J.-W. Park, S. Fracchioli, C. Vezzani, I. A. Rigault de la Longrais, W. Yao, S. C. Rubin, et al. The Oncogene Phosphatidylinositol 3'-Kinase Catalytic Subunit {alpha} Promotes Angiogenesis via Vascular Endothelial Growth Factor in Ovarian Carcinoma Cancer Res., July 15, 2003; 63(14): 4225 - 4231. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Tsao, T. McDonnell, S. Lam, J. B. Putnam, N. Bekele, W. K. Hong, and J. M. Kurie Increased Phospho-AKT (Ser473) Expression in Bronchial Dysplasia: Implications for Lung Cancer Prevention Studies Cancer Epidemiol. Biomarkers Prev., July 1, 2003; 12(7): 660 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. la Cour, J. Mollerup, P. Winding, S. Tarabykina, M. Sehested, and M. W. Berchtold Up-Regulation of ALG-2 in Hepatomas and Lung Cancer Tissue Am. J. Pathol., July 1, 2003; 163(1): 81 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Lee, H. Srinivas, D. Xia, Y. Lu, R. Superty, R. LaPushin, C. Gomez-Manzano, A. M. Gal, G. L. Walsh, T. Force, et al. Evidence That Phosphatidylinositol 3-Kinase- and Mitogen-activated Protein Kinase Kinase-4/c-Jun NH2-terminal Kinase-dependent Pathways Cooperate to Maintain Lung Cancer Cell Survival J. Biol. Chem., June 20, 2003; 278(26): 23630 - 23638. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Adjei, A. Mauer, L. Bruzek, R. S. Marks, S. Hillman, S. Geyer, L. J. Hanson, J. J. Wright, C. Erlichman, S. H. Kaufmann, et al. Phase II Study of the Farnesyl Transferase Inhibitor R115777 in Patients With Advanced Non-Small-Cell Lung Cancer J. Clin. Oncol., May 1, 2003; 21(9): 1760 - 1766. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Dai, W.-G. Zhu, C. D. Morrison, R. M. Brena, D. J. Smiraglia, A. Raval, Y.-Z. Wu, L. J. Rush, P. Ross, J. R. Molina, et al. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes Hum. Mol. Genet., April 1, 2003; 12(7): 791 - 801. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |